These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 25809254)
1. Kinetic model for NS1643 drug activation of WT and L529I variants of Kv11.1 (hERG1) potassium channel. Perissinotti LL; Guo J; De Biase PM; Clancy CE; Duff HJ; Noskov SY Biophys J; 2015 Mar; 108(6):1414-1424. PubMed ID: 25809254 [TBL] [Abstract][Full Text] [Related]
2. NS1643 interacts around L529 of hERG to alter voltage sensor movement on the path to activation. Guo J; Cheng YM; Lees-Miller JP; Perissinotti LL; Claydon TW; Hull CM; Thouta S; Roach DE; Durdagi S; Noskov SY; Duff HJ Biophys J; 2015 Mar; 108(6):1400-1413. PubMed ID: 25809253 [TBL] [Abstract][Full Text] [Related]
3. Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643. Durdagi S; Guo J; Lees-Miller JP; Noskov SY; Duff HJ J Pharmacol Exp Ther; 2012 Aug; 342(2):441-52. PubMed ID: 22573844 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a/Kv11.1b channels. Larsen AP; Bentzen BH; Grunnet M Br J Pharmacol; 2010 Oct; 161(3):614-28. PubMed ID: 20880400 [TBL] [Abstract][Full Text] [Related]
5. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Hansen RS; Diness TG; Christ T; Demnitz J; Ravens U; Olesen SP; Grunnet M Mol Pharmacol; 2006 Jan; 69(1):266-77. PubMed ID: 16219910 [TBL] [Abstract][Full Text] [Related]
6. NS1643 enhances ionic currents in a G604S-WT hERG co-expression system associated with long QT syndrome 2. Huo J; Guo X; Lu Q; Qiang H; Liu P; Bai L; Huang CL; Zhang Y; Ma A Clin Exp Pharmacol Physiol; 2017 Nov; 44(11):1125-1133. PubMed ID: 28741726 [TBL] [Abstract][Full Text] [Related]
7. Molecular determinants of human ether-à-go-go-related gene 1 (hERG1) K+ channel activation by NS1643. Grunnet M; Abbruzzese J; Sachse FB; Sanguinetti MC Mol Pharmacol; 2011 Jan; 79(1):1-9. PubMed ID: 20876384 [TBL] [Abstract][Full Text] [Related]
8. Effects of the small molecule HERG activator NS1643 on Kv11.3 channels. Bilet A; Bauer CK PLoS One; 2012; 7(11):e50886. PubMed ID: 23226420 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Casis O; Olesen SP; Sanguinetti MC Mol Pharmacol; 2006 Feb; 69(2):658-65. PubMed ID: 16284303 [TBL] [Abstract][Full Text] [Related]
10. Potent activation of large-conductance Ca2+-activated K+ channels by the diphenylurea 1,3-bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) in pituitary tumor (GH3) cells. Wu SN; Peng H; Chen BS; Wang YJ; Wu PY; Lin MW Mol Pharmacol; 2008 Dec; 74(6):1696-704. PubMed ID: 18809671 [TBL] [Abstract][Full Text] [Related]
11. Activation of ERG2 potassium channels by the diphenylurea NS1643. Elmedyb P; Olesen SP; Grunnet M Neuropharmacology; 2007 Aug; 53(2):283-94. PubMed ID: 17610913 [TBL] [Abstract][Full Text] [Related]
12. Strong activation of ether-à-go-go-related gene 1 K+ channel isoforms by NS1643 in human embryonic kidney 293 and Chinese hamster ovary cells. Schuster AM; Glassmeier G; Bauer CK Mol Pharmacol; 2011 Nov; 80(5):930-42. PubMed ID: 21856740 [TBL] [Abstract][Full Text] [Related]
13. Structure driven design of novel human ether-a-go-go-related-gene channel (hERG1) activators. Guo J; Durdagi S; Changalov M; Perissinotti LL; Hargreaves JM; Back TG; Noskov SY; Duff HJ PLoS One; 2014; 9(9):e105553. PubMed ID: 25191697 [TBL] [Abstract][Full Text] [Related]
14. Compound ICA-105574 prevents arrhythmias induced by cardiac delayed repolarization. Meng J; Shi C; Li L; Du Y; Xu Y Eur J Pharmacol; 2013 Oct; 718(1-3):87-97. PubMed ID: 24041920 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological rescue of hERG currents carried out by G604S and wide type hERG co-expression. Huo J; Zhang A; Guo X; Qiang H; Liu P; Bai L; Ma A Clin Exp Pharmacol Physiol; 2016 Sep; 43(9):851-61. PubMed ID: 27199074 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of loss of Kv11.1 K+ current in mutant T421M-Kv11.1-expressing rat ventricular myocytes: interaction of trafficking and gating. Balijepalli SY; Lim E; Concannon SP; Chew CL; Holzem KE; Tester DJ; Ackerman MJ; Delisle BP; Balijepalli RC; January CT Circulation; 2012 Dec; 126(24):2809-18. PubMed ID: 23136156 [TBL] [Abstract][Full Text] [Related]
17. Enhanced repolarization capacity: new potential antiarrhythmic strategy based on HERG channel activation. Szabó G; Farkas V; Grunnet M; Mohácsi A; Nánási PP Curr Med Chem; 2011; 18(24):3607-21. PubMed ID: 21774764 [TBL] [Abstract][Full Text] [Related]
18. Computational analysis of the effects of the hERG channel opener NS1643 in a human ventricular cell model. Peitersen T; Grunnet M; Benson AP; Holden AV; Holstein-Rathlou NH; Olesen SP Heart Rhythm; 2008 May; 5(5):734-41. PubMed ID: 18452879 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits. Bentzen BH; Bahrke S; Wu K; Larsen AP; Odening KE; Franke G; Storm vańs Gravesande K; Biermann J; Peng X; Koren G; Zehender M; Bode C; Grunnet M; Brunner M J Cardiovasc Pharmacol; 2011 Feb; 57(2):223-30. PubMed ID: 21135701 [TBL] [Abstract][Full Text] [Related]
20. The human ether-a-go-go-related gene activator NS1643 enhances epilepsy-associated KCNQ channels. Li P; Chen X; Zhang Q; Zheng Y; Jiang H; Yang H; Gao Z J Pharmacol Exp Ther; 2014 Dec; 351(3):596-604. PubMed ID: 25232191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]